Therapeutic Area
Rare Disease
Using Real World Evidence for Externally Controlled Trials in Rare Disease Drug Development
Feb 12, 2024
Key insights in managing the complexities of external control arms (ECAs) in rare disease clinical trials, garnered from ISPOR and ICPE participation and in partnership with the...